Viewing Study NCT04410627


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-19 @ 1:38 PM
Study NCT ID: NCT04410627
Status: WITHDRAWN
Last Update Posted: 2022-03-18
First Post: 2020-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HoPE (Hospice Preparation and Education)
Sponsor: Duke University
Organization:

Study Overview

Official Title: Pilot Trial Evaluating Usability, Acceptability, and Feasibility of the HoPE (Hospice Preparation and Education) Web-Based Tool
Status: WITHDRAWN
Status Verified Date: 2022-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Covid/PI Vacancy
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigator will conduct a two-site, randomized, controlled study of the HoPE (Hospice Preparation and Education) web-based tool versus usual care to assess: Technology usability (primary), study feasibility (secondary), user acceptability (secondary), and hospice service conversion rate (exploratory). Technology usability will be assessed through a one-time quantitative survey using established instruments. Study feasibility and user accessibility will be assessed through trial enrollment and retention alongside analytics assessing tool usage (e.g. time spent on each page of the website). Conversion rate is the percent of patients introduced to hospice who eventually enroll. The investigators will evaluate in an exploratory manner the differential effect of HoPE versus usual care.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: